Morodomi S, Hirosue A, Rahman A, Nohata K, Matsuo M, Reda O
Cancer Med. 2025; 14(4):e70544.
PMID: 39980140
PMC: 11842277.
DOI: 10.1002/cam4.70544.
Bellon M, Jain P, Nicot C
Viruses. 2024; 16(11).
PMID: 39599870
PMC: 11599126.
DOI: 10.3390/v16111755.
Kobayashi T, Makimoto S, Ohnuki N, Hossain M, Jahan M, Matsuo M
Microbiol Spectr. 2024; 13(1):e0171424.
PMID: 39570050
PMC: 11705797.
DOI: 10.1128/spectrum.01714-24.
Hiraga K, Kitamura T, Kuramitsu M, Murata M, Tezuka K, Okuma K
Virol J. 2024; 21(1):166.
PMID: 39080643
PMC: 11290215.
DOI: 10.1186/s12985-024-02434-7.
Hirons A, Yurick D, Jansz N, Ellenberg P, Franchini G, Einsiedel L
Retrovirology. 2024; 21(1):14.
PMID: 39014486
PMC: 11253349.
DOI: 10.1186/s12977-024-00647-w.
The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein.
Mohanty S, Suklabaidya S, Lavorgna A, Ueno T, Fujisawa J, Ngouth N
Nat Commun. 2024; 15(1):5380.
PMID: 38918393
PMC: 11199648.
DOI: 10.1038/s41467-024-49737-5.
Viral genome sequencing methods: benefits and pitfalls of current approaches.
Jansz N, Faulkner G
Biochem Soc Trans. 2024; 52(3):1431-1447.
PMID: 38747720
PMC: 11346438.
DOI: 10.1042/BST20231322.
Mcl-1 Protein and Viral Infections: A Narrative Review.
Wyzewski Z, Stepkowska J, Kobylinska A, Mielcarska A, Mielcarska M
Int J Mol Sci. 2024; 25(2).
PMID: 38256213
PMC: 10816053.
DOI: 10.3390/ijms25021138.
Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
Lv N, Zhao Y, Song Y, Ji M, Zhou Y
BMC Cancer. 2023; 23(1):1022.
PMID: 37872500
PMC: 10594741.
DOI: 10.1186/s12885-023-11529-3.
The Pleiotropic Effects of YBX1 on HTLV-1 Transcription.
Smith S, Seth J, Midkiff A, Stahl R, Syu Y, Shkriabai N
Int J Mol Sci. 2023; 24(17).
PMID: 37685922
PMC: 10487795.
DOI: 10.3390/ijms241713119.
HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma.
Katsuya H, Nakamura H, Maeda A, Ishii K, Nagaie T, Sano H
EJHaem. 2023; 4(3):733-737.
PMID: 37601876
PMC: 10435724.
DOI: 10.1002/jha2.725.
The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.
Aristodemou A, Rueda D, Taylor G, Bangham C
PLoS Pathog. 2023; 19(7):e1011494.
PMID: 37523412
PMC: 10431621.
DOI: 10.1371/journal.ppat.1011494.
Precise excision of HTLV-1 provirus with a designer-recombinase.
Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M
Mol Ther. 2023; 31(7):2266-2285.
PMID: 36934299
PMC: 10362392.
DOI: 10.1016/j.ymthe.2023.03.014.
HTLV-1 persistence and the oncogenesis of adult T-cell leukemia/lymphoma.
Bangham C
Blood. 2023; 141(19):2299-2306.
PMID: 36800643
PMC: 10646791.
DOI: 10.1182/blood.2022019332.
Clone Dynamics and Its Application for the Diagnosis of Enzootic Bovine Leukosis.
Hossain M, Kobayashi T, Makimoto S, Matsuo M, Nishikaku K, Tan B
J Virol. 2022; 97(1):e0154222.
PMID: 36533951
PMC: 9888225.
DOI: 10.1128/jvi.01542-22.
Visualization of clonal expansion after massive depletion of cells carrying the bovine leukemia virus (BLV) integration sites during the course of disease progression in a BLV naturally-infected cow: a case report.
Saito S, Hosomichi K, Polat Yamanaka M, Mizutani T, Takeshima S, Aida Y
Retrovirology. 2022; 19(1):24.
PMID: 36329491
PMC: 9635170.
DOI: 10.1186/s12977-022-00609-0.
HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system.
Tan B, Sugata K, Ono M, Satou Y
Front Immunol. 2022; 13:991928.
PMID: 36300109
PMC: 9591123.
DOI: 10.3389/fimmu.2022.991928.
A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL).
Tanaka Y, Tanaka R, Imaizumi N, Mizuguchi M, Takahashi Y, Hayashi M
Front Immunol. 2022; 13:921606.
PMID: 36177005
PMC: 9513378.
DOI: 10.3389/fimmu.2022.921606.
Alternative RNA splicing in cancer: what about adult T-cell leukemia?.
Tram J, Mesnard J, Peloponese Jr J
Front Immunol. 2022; 13:959382.
PMID: 35979354
PMC: 9376482.
DOI: 10.3389/fimmu.2022.959382.
HTLV-1 intragenic viral enhancer influences immortalization phenotype , but is dispensable for persistence and disease development in animal models.
Maksimova V, Smith S, Seth J, Phelps C, Niewiesk S, Satou Y
Front Immunol. 2022; 13:954077.
PMID: 35958554
PMC: 9359075.
DOI: 10.3389/fimmu.2022.954077.